United States · Financial press · Investor's Business Daily
Amgen, Up 41% This Year, Is Broadly Outperforming Its Peers. Here's What Its Earnings Say.
Amgen beat Wall Street's top- and bottom-line expectations late Tuesday, but there were puts and takes across the board. The post Amgen, Up 41% This Year, Is Broadly Outperforming…
Read the full article on Investor's Business Daily Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)